Drug Makers Brace for Trump’s Tariff Threat
SEOUL, Feb. 20 (Korea Bizwire) — South Korean pharmaceutical and biotech companies are scrambling to prepare for potential new tariffs threatened by American President Donald Trump on foreign-made drugs entering the U.S. market. Celltrion, a major South Korean biopharmaceutical company, announced on its website on February 19 that it has established an “optimal response system” to [...]










